Send feedback

KMT2D p.Ser1237Phe

c.3710C>T · rs374437749 · VCV2635863

Conflicting classifications of pathogenicity Conflicting submitters
Classification
Conflicting classifications of pathogenicity
ClinVar
Review
Conflicting submitters ★☆☆☆
ClinVar · 2 submitters
AlphaMissense
likely pathogenic
0.6882 · ACMG-weighted
gnomAD v4.1
Rare
very rare (popmax 0.00267%, afr)
Conditions
1
Kabuki syndrome

Computational evidence

Protein change
AlphaMissense0.6882likely pathogenic
REVEL0.368indeterminate
SaProt—not scored · why
Splicing
SpliceAI<0.2no splice effect predicted · four deltas, not one · how we know
Constraint at this position
ConservationphyloP 12GERP 2.2, phastCons 1
Regional constrainto/e 0.89unconstrained · MANE · 1,944 bp · p 0.018 · regional, not allelic
Overall
CADD24.1PHRED · no single calibrated threshold — expert panels disagree

AlphaMissense carries the ACMG weight for missense; REVEL is an independent agreement signal.

Population frequency

gnomAD v4.1 · exomes + genomes
Grpmax group 0.00267% African / African-American · 2/74,936 alleles
Filtering AF 0.0013% ClinGen BA1/BS1 input FAF95, joint · FAF99 0.00108%
Overall 0.0018% 29/1,613,774 alleles · very rare exomes 27/1,461,562 · genomes 2/152,212 · joint denominator
Ancestry group Frequency 1 in
Remaining individualsnot grpmax-eligible 0.0048% 20,821
African / African-Americangrpmax 0.00267% 37,468
European (non-Finnish) 0.00195% 51,299
South Asian 0.0011% 91,086

Remaining individuals shows a higher raw frequency than the grpmax group above it. gnomAD excludes bottlenecked groups — Finnish, Ashkenazi Jewish, Amish and “Remaining individuals” — from grpmax, because founder effects make their frequencies unrepresentative for filtering. The table is sorted by frequency, so an excluded group can sit above the grpmax row.

Rarity supports pathogenicity (ACMG PM2); frequency above a disease-specific BA1/BS1 threshold argues against it. A variant frequent in one ancestry group can be near-absent in others, so a single global figure can mislead.

Variant & gene context

Gene
KMT2D
Protein
p.Ser1237Phe
Coding
c.3710C>T
MANE Select
NM_003482
dbSNP
rs374437749
Type
single nucleotide variant
Location
chr12:49049878 (GRCh38)
Gene constraint
LOEUF 0.141 · pLI 1.00 · ClinGen HI 3/3 (gnomAD)
Residue 1237
a UniProt-annotated variant site (in kabuk1); the 'disordered' region
Full KMT2D gene report on Sugi Atlas → Gene function, pathways, protein structure, interactions & more

Similar variants

Built on 18 open, versioned datasets — ClinVar, gnomAD, AlphaMissense, REVEL, ClinGen & more — plus Sugi Variant's own cross-source analysis. Source data 2026-01–2026-10, ClinVar 2026-10. Full sources & versions →

Cite Sugi Variant

Gür T. Sugi Variant: A Deterministic Per-Variant Germline Reference from a Knowledge Graph for Humans and AI Agents. 2026. doi:10.5281/zenodo.21509445. This variant: https://sugi.bio/variant/kmt2d-p-ser1237phe (accessed [today's date]).

Preprint & method: sugi.bio/variant/method Machine-readable: this page as Markdown